Pulmonx Corporation
LUNG
NASDAQ·Healthcare·Medical - Devices·Mkt cap $95.5M
$2.21
▼ -2.21%
P/E
-1.92
Mkt Cap
$95.5M
52-Wk Range
$1.13–$2.89
52-Week Range
$1.13 - $2.89
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 29.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary endobronchial valve technology with established clinical efficacy and safety profile
- Integrated diagnostic-to-therapeutic platform creating procedural workflow efficiency and switching costs
- Extensive clinical evidence base and physician training network supporting market adoption
- Regulatory clearances across major markets (FDA, CE Mark) with expanding international presence
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
Stable outlook
Rising COPD prevalence and aging global population increasing emphysema patient population
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+39.5% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying LUNG right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
JUL 29, 2026
Reported EPS of -$0.24 vs -$0.28 consensus (+14.3% surprise). Revenue of $22.8M vs $22.4M expected (+1.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+14.3%
Revenue trend · last 8Q
—
+23%
+20%
+15%
+5%
-5%
-9%
-5%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$20.4M
$23.8M
$22.5M
$23.9M
$21.5M
$22.6M
$20.6M
$22.8M
Margins · last 8Q
Gross
78.0%
Operating
-39.8%
Profit
-44.3%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: D. Boral Capital · Apr 30, 2026
vs Industry
How LUNG stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related